Geistlich Pharma AG (Geistlich) is a global leader dedicated to advancing regenerative medicine and develops, produces and markets medical products for the restoration of bone, cartilage and soft tissue as well as pharmaceuticals. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 affiliates and 60 distributors, the company reaches around 90 markets and employs over 800 people.